End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
59.5 ZAR | +0.22% |
|
+0.76% | -1.00% |
Feb. 21 | Adcock Ingram Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Feb. 21 | Transcript : Adcock Ingram Holdings Limited, H1 2024 Earnings Call, Feb 21, 2024 |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-1.00% | 483M | B | ||
+26.92% | 45.55B | B- | ||
+33.33% | 23.65B | B+ | ||
+21.42% | 14.62B | B+ | ||
+71.23% | 14.04B | B | ||
-0.05% | 6.79B | - | - | |
-13.71% | 6.36B | B+ | ||
+15.70% | 5.77B | B+ | ||
-8.87% | 5.73B | - | - | |
+12.06% | 4.8B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- AIP Stock
- Ratings Adcock Ingram Holdings Limited